Aardvark Therapeutics (AARD) News Today $7.00 -0.57 (-7.53%) As of 04/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Aardvark Therapeutics (NASDAQ:AARD) Earns "Outperform" Rating from Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and issued a $21.00 target price on shares of Aardvark Therapeutics in a research report on Tuesday.April 3, 2025 | marketbeat.comAardvark Therapeutics' (AARD) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and set a $50.00 price target on shares of Aardvark Therapeutics in a report on Tuesday.April 2, 2025 | marketbeat.comAARD Aardvark Therapeutics, Inc.April 2, 2025 | seekingalpha.comRBC Capital Sticks to Their Buy Rating for Aardvark Therapeutics, Inc. (AARD)April 2, 2025 | markets.businessinsider.comAardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business HighlightsMarch 31, 2025 | globenewswire.comAardvark Therapeutics (NASDAQ:AARD) Price Target Raised to $26.00 at Bank of AmericaBank of America boosted their price target on shares of Aardvark Therapeutics from $22.00 to $26.00 and gave the company a "buy" rating in a research note on Thursday.March 28, 2025 | marketbeat.comDrugmaker Soleno Soars on Approval to Treat Never Ending HungerMarch 27, 2025 | finance.yahoo.comAardvark Therapeutics price target raised to $26 from $22 at BofAMarch 27, 2025 | markets.businessinsider.comSoleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, But Aardvark Reverses LowerMarch 27, 2025 | msn.comSoleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, Pulling Aardvark HigherMarch 27, 2025 | msn.comAardvark Therapeutics Inc Share Price (AARD.US)March 21, 2025 | lse.co.ukAardvark Therapeutics, Inc. Common Stock (AARD): Among Top Insider Purchases Last MonthMarch 14, 2025 | msn.comAardvark Therapeutics initiated with an Overweight at Cantor FitzgeraldMarch 12, 2025 | markets.businessinsider.comAardvark Therapeutics initiated with an Outperform at RBC CapitalMarch 11, 2025 | markets.businessinsider.comAardvark Therapeutics initiated with a Buy at BofAMarch 11, 2025 | markets.businessinsider.comBiotechs Highlight 6 Stocks Insiders Are Buying NowFebruary 23, 2025 | 247wallst.comAardvark Therapeutics, Inc. (NASDAQ:AARD) CFO Purchases $160,000.00 in StockFebruary 20, 2025 | insidertrades.comU.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO WeekFebruary 15, 2025 | seekingalpha.com Get Aardvark Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AARD and its competitors with MarketBeat's FREE daily newsletter. Email Address AARD Media Mentions By Week AARD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AARD News Sentiment▼0.000.49▲Average Medical News Sentiment AARD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AARD Articles This Week▼02▲AARD Articles Average Week Get Aardvark Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AARD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NRIX News ZYME News CRON News CVAC News PHVS News ABCL News CDXC News XERS News EOLS News ABUS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AARD) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aardvark Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aardvark Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AARD Stock Free AARD Stock Alerts